In silico and in vitro evaluation of newly synthesized pyrazolo-pyridine fused tetrazolo-pyrimidines derivatives as potential anticancer and antimicrobial agents.

IF 2.7 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Harsh C Patel, Manan S Patel, Jaydeepkumar N Parekh, Dipakkumar D Chudasama, Priyanka Dalwadi, Anju Kunjadiya, Vaibhav Bhatt, Krunal M Modi, Chirag N Patel, Kesur R Ram
{"title":"In silico and in vitro evaluation of newly synthesized pyrazolo-pyridine fused tetrazolo-pyrimidines derivatives as potential anticancer and antimicrobial agents.","authors":"Harsh C Patel, Manan S Patel, Jaydeepkumar N Parekh, Dipakkumar D Chudasama, Priyanka Dalwadi, Anju Kunjadiya, Vaibhav Bhatt, Krunal M Modi, Chirag N Patel, Kesur R Ram","doi":"10.1080/07391102.2023.2298731","DOIUrl":null,"url":null,"abstract":"<p><p>Diversely functionalized pyrazolo-pyridine fused tetrazolo-pyrimidines <b>10aa-am</b> and <b>10ba-bn</b> were successfully synthesized <i>via</i> a catalyst-free synthetic protocol with moderate to very good yields. The compounds were evaluated for cytotoxicity against MCF-7 and HEK-293 cells using MTT assay. Among the tested compounds, <b>10ab</b> (IC<sub>50</sub>- 23.83 µM) and <b>10ah</b> (IC<sub>50</sub>- 23.30 µM) demonstrated the highest potency against MCF-7 cells, while <b>10bc</b> (IC<sub>50</sub>- 14.46 µM) and <b>10bh</b> (IC<sub>50</sub>- 2.53 µM) exhibited excellent cytotoxicity against HEK-293 cells. Additionally, antibacterial screening was performed against three Gram-negative bacteria (<i>E. coli, P. aeruginosa,</i> and <i>S. enterica</i>) and three Gram-positive bacteria (<i>S. aureus, B. megaterium, and B. subtilis</i>) using broth dilution method, while antifungal activity was assessed against three fungal strains (<i>A. niger, Penicillium, and S. cerevisiae</i>) using agar well diffusion method. In antimicrobial screening, the majority of the compounds demonstrated significant antibacterial efficacy compared to antifungal activity. We also conducted comprehensive computational studies, including DFT calculations, molecular docking and dynamics, and drug-likeness assessments. In the DFT study, compounds <b>10ac</b> and <b>10bc</b> displayed stable conformations, indicating their potential for higher therapeutic activity. Molecular docking analyses revealed compelling interactions, with compound <b>10ah</b> demonstrating docking score -7.42 kcal/mol against catalytical domain PARP1 (PDB ID: 7KK4) and <b>10bh</b> exhibiting a best docking score -10.77 kcal/mol against human corticotropin-releasing factor receptor 1 (PDB ID: 4Z9G). A 100 ns molecular dynamics (MD) simulation study of compounds <b>10ah</b> and <b>10bh</b> revealed the stable conformation and binding energy in a stimulating environment. In drug-likeness assessments, both the compounds <b>10ah</b> and <b>10bh</b> adhere all the established guidelines.</p>","PeriodicalId":15272,"journal":{"name":"Journal of Biomolecular Structure & Dynamics","volume":" ","pages":"3467-3490"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomolecular Structure & Dynamics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/07391102.2023.2298731","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Diversely functionalized pyrazolo-pyridine fused tetrazolo-pyrimidines 10aa-am and 10ba-bn were successfully synthesized via a catalyst-free synthetic protocol with moderate to very good yields. The compounds were evaluated for cytotoxicity against MCF-7 and HEK-293 cells using MTT assay. Among the tested compounds, 10ab (IC50- 23.83 µM) and 10ah (IC50- 23.30 µM) demonstrated the highest potency against MCF-7 cells, while 10bc (IC50- 14.46 µM) and 10bh (IC50- 2.53 µM) exhibited excellent cytotoxicity against HEK-293 cells. Additionally, antibacterial screening was performed against three Gram-negative bacteria (E. coli, P. aeruginosa, and S. enterica) and three Gram-positive bacteria (S. aureus, B. megaterium, and B. subtilis) using broth dilution method, while antifungal activity was assessed against three fungal strains (A. niger, Penicillium, and S. cerevisiae) using agar well diffusion method. In antimicrobial screening, the majority of the compounds demonstrated significant antibacterial efficacy compared to antifungal activity. We also conducted comprehensive computational studies, including DFT calculations, molecular docking and dynamics, and drug-likeness assessments. In the DFT study, compounds 10ac and 10bc displayed stable conformations, indicating their potential for higher therapeutic activity. Molecular docking analyses revealed compelling interactions, with compound 10ah demonstrating docking score -7.42 kcal/mol against catalytical domain PARP1 (PDB ID: 7KK4) and 10bh exhibiting a best docking score -10.77 kcal/mol against human corticotropin-releasing factor receptor 1 (PDB ID: 4Z9G). A 100 ns molecular dynamics (MD) simulation study of compounds 10ah and 10bh revealed the stable conformation and binding energy in a stimulating environment. In drug-likeness assessments, both the compounds 10ah and 10bh adhere all the established guidelines.

对新合成的吡唑并吡啶融合四唑并嘧啶衍生物作为潜在抗癌和抗菌剂的硅学和体外评估。
通过一种无催化剂合成方案,成功合成了具有多种功能的吡唑并吡啶融合四唑并嘧啶 10aa-am 和 10ba-bn,收率从中等到非常好。采用 MTT 法评估了这些化合物对 MCF-7 和 HEK-293 细胞的细胞毒性。在测试的化合物中,10ab(IC50- 23.83 µM)和 10ah(IC50- 23.30 µM)对 MCF-7 细胞的效力最高,而 10bc(IC50- 14.46 µM)和 10bh(IC50- 2.53 µM)对 HEK-293 细胞的细胞毒性极佳。此外,还采用肉汤稀释法对三种革兰氏阴性菌(大肠杆菌、绿脓杆菌和肠球菌)和三种革兰氏阳性菌(金黄色葡萄球菌、巨大芽孢杆菌和枯草杆菌)进行了抗菌筛选,并采用琼脂井扩散法对三种真菌菌株(黑曲霉、青霉和葡萄孢)进行了抗真菌活性评估。在抗菌筛选中,与抗真菌活性相比,大多数化合物都表现出了显著的抗菌效果。我们还进行了全面的计算研究,包括 DFT 计算、分子对接和动力学以及药物相似性评估。在 DFT 研究中,化合物 10ac 和 10bc 显示出稳定的构象,表明它们具有更高的治疗活性潜力。分子对接分析表明,化合物 10ah 与催化域 PARP1(PDB ID:7KK4)的对接得分为 -7.42 kcal/mol,而 10bh 与人促肾上腺皮质激素释放因子受体 1(PDB ID:4Z9G)的最佳对接得分为 -10.77 kcal/mol。对化合物 10ah 和 10bh 进行的 100 ns 分子动力学(MD)模拟研究显示了其在刺激环境中的稳定构象和结合能。在药物相似性评估中,化合物 10ah 和 10bh 均符合所有既定准则。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biomolecular Structure & Dynamics
Journal of Biomolecular Structure & Dynamics 生物-生化与分子生物学
CiteScore
8.90
自引率
9.10%
发文量
597
审稿时长
2 months
期刊介绍: The Journal of Biomolecular Structure and Dynamics welcomes manuscripts on biological structure, dynamics, interactions and expression. The Journal is one of the leading publications in high end computational science, atomic structural biology, bioinformatics, virtual drug design, genomics and biological networks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信